Profile for Lithuania Patent: C2826776
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Lithuania Patent: C2826776
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,081,621 | Mar 25, 2031 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 10,081,621 | Mar 25, 2031 | Vertex Pharms Inc | ALYFTREK | deutivacaftor; tezacaftor; vanzacaftor calcium |
| 10,081,621 | Mar 25, 2031 | Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor |
| 11,578,062 | Mar 25, 2031 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| 11,578,062 | Mar 25, 2031 | Vertex Pharms Inc | ALYFTREK | deutivacaftor; tezacaftor; vanzacaftor calcium |
| 11,578,062 | Mar 25, 2031 | Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
